Lantern Pharma (LTRN)

• Market cap: $26.5M
• 1 day: -4.17%
• 5 days: -8.81%
• 1 month: -20.38%
• 3 months: -40.86%
• 6 months: -22.76%
• Year to date: -33.44%
• 1 year: -49.01%
• 5 years: -84.88%
• 10 years: -86.15%
• Sector: Healthcare
• Industry: Biotechnology

About: Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Employees: 16